PhaseRx, Inc.
PZRX
PZRX was delisted on the 2nd of February, 2018.
8 hedge funds and large institutions have $5.41M invested in PhaseRx, Inc. in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.94M |
| 2 |
PA
Perceptive Advisors
New York
|
+$988K |
| 3 |
RFC
Regions Financial Corp
Birmingham,
Alabama
|
+$207K |
| 4 |
Goldman Sachs
New York
|
+$91.4K |
| 5 |
Millennium Management
New York
|
+$53K |
Top Sellers
PZRX Hedge Fund Activity: Q2 2016 in Review
8 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in PhaseRx, Inc. (PZRX) for Q2 2016, worth a combined $5.41M.
Buyers outnumbered sellers: 8 funds opened new PZRX positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $4.94M.
- 8 institutional investors held PhaseRx, Inc. (PZRX) as of Q2 2016, up from 0 in Q1 2016.
- Funds reported $5.41M of PhaseRx, Inc. stock for Q2 2016.
- 8 funds opened new PhaseRx, Inc. positions in Q2 2016 and 0 closed out, a net change of +8 holders.
- The largest PhaseRx, Inc. buyer in Q2 2016 was Fidelity Investments, an estimated $4.94M added.
Based on aggregated 13F filings for Q2 2016.